Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PDA-Based Glyconanomicelles for Hepatocellular Carcinoma Cells Active Targeting Via Mannose and Asialoglycoprotein Receptors.
Negrete M, Romero-Ben E, Gutiérrez-Valencia A, Rosales-Barrios C, Alés E, Mena-Barragán T, Flores JA, Castillejos MC, de la Cruz-Ojeda P, Navarro-Villarán E, Cepeda-Franco C, Khiar N, Muntané J. Negrete M, et al. Among authors: muntane j. ACS Appl Bio Mater. 2021 Jun 21;4(6):4789-4799. doi: 10.1021/acsabm.0c01679. Epub 2021 Jun 7. ACS Appl Bio Mater. 2021. PMID: 35007028
Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells.
Rodríguez-Hernández MA, de la Cruz-Ojeda P, Gallego P, Navarro-Villarán E, Staňková P, Del Campo JA, Kučera O, Elkalaf M, Maseko TE, Červinková Z, Muntané J. Rodríguez-Hernández MA, et al. Among authors: muntane j. Biochem Pharmacol. 2020 Jun;176:113902. doi: 10.1016/j.bcp.2020.113902. Epub 2020 Mar 7. Biochem Pharmacol. 2020. PMID: 32156660
Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
Navarro-Villarán E, de la Cruz-Ojeda P, Contreras L, González R, Negrete M, Rodríguez-Hernández MA, Marín-Gómez LM, Álamo-Martínez JM, Calvo A, Gómez-Bravo MA, de la Cruz J, Padillo J, Muntané J. Navarro-Villarán E, et al. Among authors: muntane j. Cell Physiol Biochem. 2020 May 6;54(3):457-473. doi: 10.33594/000000230. Cell Physiol Biochem. 2020. PMID: 32369692 Free article.
Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells.
Rodríguez-Hernández MA, Chapresto-Garzón R, Cadenas M, Navarro-Villarán E, Negrete M, Gómez-Bravo MA, Victor VM, Padillo FJ, Muntané J. Rodríguez-Hernández MA, et al. Among authors: muntane j. Cell Death Dis. 2020 May 7;11(5):339. doi: 10.1038/s41419-020-2558-1. Cell Death Dis. 2020. PMID: 32382022 Free PMC article.
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.
de la Cruz-Ojeda P, Schmid T, Boix L, Moreno M, Sapena V, Praena-Fernández JM, Castell FJ, Falcón-Pérez JM, Reig M, Brüne B, Gómez-Bravo MA, Giráldez Á, Bruix J, Ferrer MT, Muntané J. de la Cruz-Ojeda P, et al. Among authors: muntane j. Cells. 2022 Aug 28;11(17):2673. doi: 10.3390/cells11172673. Cells. 2022. PMID: 36078082 Free PMC article.
Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer.
González R, Rodríguez-Hernández MA, Negrete M, Ranguelova K, Rossin A, Choya-Foces C, Cruz-Ojeda P, Miranda-Vizuete A, Martínez-Ruiz A, Rius-Pérez S, Sastre J, Bárcena JA, Hueber AO, Padilla CA, Muntané J. González R, et al. Among authors: muntane j. Redox Biol. 2020 Jul;34:101528. doi: 10.1016/j.redox.2020.101528. Epub 2020 Apr 4. Redox Biol. 2020. PMID: 32388267 Free PMC article.
The Role of Non-Coding RNAs in Autophagy During Carcinogenesis.
de la Cruz-Ojeda P, Flores-Campos R, Navarro-Villarán E, Muntané J. de la Cruz-Ojeda P, et al. Among authors: muntane j. Front Cell Dev Biol. 2022 Mar 2;10:799392. doi: 10.3389/fcell.2022.799392. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35309939 Free PMC article. Review.
Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma.
Rojas Á, Gil-Gómez A, de la Cruz-Ojeda P, Muñoz-Hernández R, Sánchez-Torrijos Y, Gallego-Durán R, Millán R, Rico MC, Montero-Vallejo R, Gato-Zambrano S, Maya-Miles D, Ferrer MT, Muntané J, Robles-Frías MJ, Ampuero J, Padillo FJ, Romero-Gómez M. Rojas Á, et al. Among authors: muntane j. Liver Int. 2022 Jun;42(6):1410-1422. doi: 10.1111/liv.15230. Epub 2022 Mar 12. Liver Int. 2022. PMID: 35243752
191 results